FEDERATED HERMES, INC. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 193 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$38
-100.0%
15
-100.0%
0.00%
-100.0%
Q2 2022$781,000
+78000.0%
280,100
+14004900.0%
0.00%
Q1 2022$1,000
-99.7%
2
-100.0%
0.00%
-100.0%
Q1 2020$299,000
+1.7%
25,462
+173.8%
0.00%0.0%
Q3 2018$294,000
-96.1%
9,298
-95.2%
0.00%
-95.5%
Q2 2018$7,486,000
+193.8%
192,678
+108.7%
0.02%
+214.3%
Q1 2018$2,548,000
+96.6%
92,305
+28.9%
0.01%
+75.0%
Q4 2017$1,296,000
-58.5%
71,597
-80.9%
0.00%
-60.0%
Q3 2014$3,124,000
-32.4%
375,0000.0%0.01%
-28.6%
Q2 2014$4,620,000375,0000.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders